Work

Lenalidomide Has Activity in a Phase II Trial in Patients with Primary Systemic Amyloidosis.

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.252.252

Authors: Angela Dispenzieri, Martha Q. Lacy, Steven R. Zeldenrust, Susan M. Geyer, John A. Lust, Suzanne R. Hayman, Shaji K. Kumar, Jacob B. Allred, S. Vincent Rajkumar, Brian Kabat, Thomas E. Witzig, Philip R. Greipp, Steven R. Russell, Irene Ghobrial, Morie A. Gertz

Institutions: Mayo Clinic, University of Pittsburgh

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588176002

FWCI: 0.346

Cites:

Cited by: 3

Related to: 10